277 related articles for article (PubMed ID: 10922099)
1. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
2. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.
Cereda M; Trocino G; Pogliani EM; Schiavina R
Ital Heart J; 2003 Jan; 4(1):60-3. PubMed ID: 12690924
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing graft versus host disease.
O'Rourke ME; High K
Clin J Oncol Nurs; 2000; 4(1):47-8. PubMed ID: 10865586
[No Abstract] [Full Text] [Related]
4. Esophageal graft-versus-host disease.
Hatcher JL; Wright SC; Lintzenich CR
Ear Nose Throat J; 2013 Feb; 92(2):64. PubMed ID: 23460213
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
[No Abstract] [Full Text] [Related]
6. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
[TBL] [Abstract][Full Text] [Related]
8. Bowel permeability tests and acute graft-versus-host disease.
Fegan CD; Whitaker JA
Bone Marrow Transplant; 1995 May; 15(5):814-6. PubMed ID: 7670415
[No Abstract] [Full Text] [Related]
9. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
[TBL] [Abstract][Full Text] [Related]
11. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
12. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
13. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
15. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
[No Abstract] [Full Text] [Related]
16. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
17. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
18. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
[TBL] [Abstract][Full Text] [Related]
20. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease.
Facon T; Jouet JP; Noel-Walter MP; Bloget F; Bauters F; Janin A
Bone Marrow Transplant; 1997 Sep; 20(6):511-5. PubMed ID: 9313887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]